What You Need to Know About the H7N9 Vaccine
A New Vaccine for an Old Virus
The H7N9 vaccine is a new vaccine that protects against the H7N9 influenza virus. The H7N9 virus is a type of influenza A virus that can cause severe respiratory illness in humans. The virus was first identified in China in 2013, and has since spread to other countries in Asia and Europe.
The H7N9 vaccine is made from a weakened form of the H7N9 virus. The vaccine is given as a single injection, and it is recommended for people who are at high risk of exposure to the virus, such as healthcare workers, travelers to affected areas, and people with weakened immune systems.
Clinical Trials
The H7N9 vaccine has been shown to be safe and effective in clinical trials. In one study, the vaccine was found to be 95% effective in preventing severe respiratory illness caused by the H7N9 virus.
The vaccine is also well-tolerated. The most common side effects are pain, redness, and swelling at the injection site. These side effects are usually mild and go away within a few days.
Availability
The H7N9 vaccine is currently available in the United States and other countries. The vaccine is recommended for people who are at high risk of exposure to the virus. If you are unsure if you should get the vaccine, talk to your doctor.
Conclusion
The H7N9 vaccine is a new vaccine that protects against the H7N9 influenza virus. The vaccine is safe and effective, and it is recommended for people who are at high risk of exposure to the virus.
Comments